Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Liquick X-treme catheter paediatric 8Ch-10Ch
21020001584
|
Liquick X-treme catheter paediatric 8Ch-10Ch | Catheters | Appliances | No data available |
|
Liquick X-treme Plus catheter male Tiemann tip 12Ch-16Ch
21020001603
|
Liquick X-treme Plus catheter male Tiemann tip 12Ch-16Ch | Catheters | Appliances | No data available |
|
Liquid paraffin 16% lotion
130201000AAASAS
|
Generic compound emollients | Other emollient preparations | Skin | No data available |
|
Liquid paraffin 91.7% / Lanolin 3% bath oil
1302011M0AAAAAA
|
Liquid paraffin | Liquid paraffin | Skin | No data available |
|
Liquid paraffin eye drops
1108010L0AAAAAA
|
Liquidparaffin (Eye) | Liquid paraffin | Eye | No data available |
|
Liquid paraffin light 37.8%/Isopropyl myristate 13% bath add
1302011L0AAAAAA
|
Light liquid paraffin | Light liquid paraffin | Skin | No data available |
|
Liquid paraffin light 69.6% / Almond oil 30% bath oil
1302011L0AAABAB
|
Light liquid paraffin | Light liquid paraffin | Skin | No data available |
|
Liquid paraffin light eye drops
1108010L0AAACAC
|
Liquidparaffin (Eye) | Liquid paraffin | Eye | No data available |
|
Liquid paraffin oral emulsion
0106030P0AAAAAA
|
Liq paraf (Systemic) | Liquid paraffin | Gastro-Intestinal System | No data available |
|
Liquorice liq ext 125microL/Ipecac liq ext 5microL/5ml soln
0309020T0AAAGAG
|
Ipecacuanha | Ipecacuanha | Respiratory System | No data available |
|
Liquorice liquid extract
190603000AAALAL
|
Generic co prepn bnf 1906030 | Other extract preparations | Other Drugs and Preparations | No data available |
|
Liquorice root tincture
190606000BCUZA0
|
Proprietary compound preparation BNF 1906060 | Other tincture preparations | Other Drugs and Preparations | No data available |
|
Lisicostad 10mg/12.5mg tablets
0205051K0BEAAAB
|
Lisicostad | Lisinopril with diuretic | Cardiovascular System | No data available |
|
Lisicostad 20mg/12.5mg tablets
0205051K0BEABAA
|
Lisicostad | Lisinopril with diuretic | Cardiovascular System | No data available |
|
Lisinopril 10mg/5ml oral liquid
0205051L0AAAHAH
|
Lisinopril | Lisinopril | Cardiovascular System | No data available |
|
Lisinopril 14mg/5ml oral liquid
0205051L0AAATAT
|
Lisinopril | Lisinopril | Cardiovascular System | No data available |
|
Lisinopril 30mg/5ml oral liquid
0205051L0AAAJAJ
|
Lisinopril | Lisinopril | Cardiovascular System | No data available |
|
Lisinopril 37.5mg/5ml oral liquid
0205051L0AAASAS
|
Lisinopril | Lisinopril | Cardiovascular System | No data available |
|
Lisinopril 40mg/5ml oral suspension
0205051L0AAARAR
|
Lisinopril | Lisinopril | Cardiovascular System | No data available |
|
Lisinopril 500micrograms/5ml oral liquid
0205051L0AAAMAM
|
Lisinopril | Lisinopril | Cardiovascular System | No data available |
|
Lisopress 10mg tablets
0205051L0BEACAC
|
Lisopress | Lisinopril | Cardiovascular System | No data available |
|
Lisopress 20mg tablets
0205051L0BEADAD
|
Lisopress | Lisinopril | Cardiovascular System | No data available |
|
Lisopress 5mg tablets
0205051L0BEABAB
|
Lisopress | Lisinopril | Cardiovascular System | No data available |
|
Lisuride 200microgram tablets
0409010L0AAAAAA
|
Lisuride maleate | Lisuride maleate | Central Nervous System | No data available |
|
Litak 10mg/5ml solution for injection vials
0801030C0BCAAAB
|
Litak | Cladribine | Malignant Disease and Immunosuppression | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.